These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A 73-year-old man with symptomatic benign prostatic hyperplasia. Barry MJ JAMA; 1997 Dec 24-31; 278(24):2178-84. PubMed ID: 9417013 [No Abstract] [Full Text] [Related]
8. Current treatment options for benign prostatic hyperplasia and their impact on sexual function. Larson TR Urology; 2003 Apr; 61(4):692-8. PubMed ID: 12670545 [No Abstract] [Full Text] [Related]
9. Benign prostatic hyperplasia. Medical and minimally invasive treatment options. Oesterling JE N Engl J Med; 1995 Jan; 332(2):99-109. PubMed ID: 7527494 [No Abstract] [Full Text] [Related]
10. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia. Agha AH; Roy JB; Culkin DJ; Lyon K Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332 [TBL] [Abstract][Full Text] [Related]
11. [New therapeutic trends in benign hypertrophy of the prostate]. Chatelain C Chirurgie; 1999 Jun; 124(3):223-31. PubMed ID: 10429295 [No Abstract] [Full Text] [Related]
12. Benign prostatic hyperplasia (BPH). Harv Mens Health Watch; 2006 Aug; 11(1):3. PubMed ID: 17111474 [No Abstract] [Full Text] [Related]
13. Medical treatment as an alternative to surgery in the management of benign prostatic hypertrophy. Bredin HC Ir Med J; 1996; 89(3):86, 88. PubMed ID: 8707527 [No Abstract] [Full Text] [Related]
14. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination]. Hausmann R; Thalmann G; Reich O; Steif CG Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991 [No Abstract] [Full Text] [Related]